ARCpoint Inc. operates a franchise system providing various testing and screening services in the healthcare sector. While it boasts a high gross margin of 83.9%, its negative EBITDA and net margins indicate significant operational challenges, leading to a low financial health score of 38/100. The current ratio of 0.05 raises liquidity concerns, suggesting potential difficulties in meeting short-term obligations. Despite its strong gross margin, the low market cap and share price reflect investor skepticism about its profitability and financial stability.
Loading financial metrics...
Company has $5K in cash but burned $321K last quarter. At this burn rate, only 0.0 quarters of runway remain without additional financing.
Revenue fell 73.0% year-over-year from $2.2M to $606K. The decline has persisted for multiple quarters.
Company posted a loss of $-2.1M over the last year, representing 349.3% of revenue.
Debt of $8.5M is 1724.1x the company's cash position of $5K.
Operating cash flow has been negative for 3 consecutive quarters, burning $1.3M over the last year.
Gross margin expanded by 9.5 percentage points, indicating improved pricing power or cost efficiency.
Exceptional gross margin of 83.9% indicates strong pricing power and competitive moat.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Diagnostics & Research companies of a similar size
Based on 2025-FY (December 31, 2025)